Autopsy report · NCT01607866
Quadrant Versus Superficial Parotidectomy
Cause of deathSlow enrollment
“Lack of enrollment of eligible patients for randomization.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2, Phase 3
- Sponsor
- Mansoura University
- Sponsor type
- University, hospital or other
- Conditions
- Pleomorphic Adenoma of the Parotid Gland
- Interventions
- Quadrant parotidectomy; Superficial parotidectomy
- Participants
- 0
- Sites
- 1
- Countries
- Egypt
Trials that died the same way
- Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
“Lack of patient enrollment” - Human Brain Adaptation to Chronic Pain and Its Effects on Opioid Use
“Insufficient patient enrollment.” - The Effect of Thalidomide in Suppression of the Systemic Inflammatory Response Syndrome in Hemodialysis Patients
“Low enrollment -- We could not recruit patients willing to be enrolled” - Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients
“Hard to enroll expected number of eligible patients.” - The Use of Tolvaptan to Prevent Renal Dysfunction in High Risk Patients With Heart Failure-Pilot Study
“Lack of eligible patients”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.